Thank you for participating in this survey conducted by the U.S. Medical Compression Alliance (USMCA). Your input is essential in helping us understand the current landscape of reimbursement and billing for Lymphedema Treatment Act (LTA)-related products.
With the recent implementation of the LTA and the introduction of new HCPCS codes, we aim to gather insights on how these changes are affecting providers, suppliers, and patients. This information will allow us to identify challenges, trends, and areas where USMCA can best support the industry through advocacy, education, and resource development.
Your responses will remain confidential and will be used solely to enhance industry-wide efforts to improve reimbursement processes and patient access to essential medical compression products.
We appreciate your time and expertise in completing this survey. Your feedback will help shape the future of medical compression reimbursement and industry support.
